Arthneeti

Apollo Hospitals Enterprise Q1 FY27 Share Price & Earnings Call Analysis

₹8,448.00+3.02% today
Market cap
₹1.21L Cr
P/E
57.75
ROE
21.15%
PEG
1.79
Price to sales
4.59
Debt to equity
0.90
52W high / low
₹9,069 / ₹6,794
Sales growth (5Y)
19.03%
EBITDA margin
15.17%
Net profit margin
7.65%
Promoter holding
28.02%
Sales (last year)
₹26,430 Cr

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country.

Guidance scorecard · Q1 FY27 call

What Apollo Hospitals Enterprise Ltd's management guided
and where it ranks in Healthcare Services

#6of 33 in
Healthcare Services
Revenue20–40%MarginsFlatCapexPlannedFundraisingWhat management saidOrder bookWhat management said

RevenueQ1 FY27 call

20–40%
  • Full-year revenue growth target for hospitals is around 18% to 20%.
  • Established hospitals expected to grow 13% to 14% over the next 24 months.
  • New hospitals are expected to add around 7% to revenue growth during the same period.
  • IP volume growth for established units guided at roughly 7% to 8%.
  • Bangladesh patient volumes normalizing, resulting in higher volume growth (60%-70% recovery).
  • Digital pharmacy and diagnostics businesses aiming for 20%-30% growth.
  • Insurance business is growing rapidly (around 80% growth) but still in investment phase, expected to breakeven by Q3 of FY27.

2 more points from Apollo Hospitals Enterprise Ltd's call on revenue

Create a free account to keep reading this call

Full Q1 FY27 analysis

MarginsQ1 FY27 call

Flat

Ask what Apollo Hospitals Enterprise Ltd said on margins →

Full Q1 FY27 analysis

CapexQ1 FY27 call

Planned
  • Apollo Hospitals is commissioning new hospitals, including the upcoming Gurgaon hospital with a soft launch in September and full opening in October, contributing to revenue from Q4 onwards.
  • Plans for a new Proton center in Delhi are underway, with location options to be shared soon; the existing Chennai Proton center is operating near full capacity.
  • Capital investment continues to focus on expanding and upgrading facilities, such as renovation of the Teynampet hospital in Chennai.
  • The company is also investing in digital businesses, diagnostics, primary care, and insurance platforms to build an integrated healthcare ecosystem.
  • The mother and child business transaction is pending regulatory clearance, after which the focus will intensify on diagnostics and primary care growth.

2 more points from Apollo Hospitals Enterprise Ltd's call on capex

Create a free account to keep reading this call

Full Q1 FY27 analysis

FundraisingQ1 FY27 call

See what Apollo Hospitals Enterprise Ltd said on fundraising — free account, 30 seconds.

Full Q1 FY27 analysis

Order bookQ1 FY27 call

  • The discussion primarily focuses on business strategies, hospital closures, patient volumes, insurance business, and new healthcare offerings such as proton therapy centers. There is no direct reference to order book status or pending orders for Apollo…
Full Q1 FY27 analysis
Full Healthcare Services ranking

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Healthcare Services
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Aster DM Quality Care LtdGood growth
    3
See all potential multibaggersWhere does Apollo Hospitals Enterprise Ltd rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Healthcare Services companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 2%+₹903 Cr—
240%+Flat₹583 Cr22.2
3Aster DM Quality Care Ltd20–40%Up 2%+₹58,782 Cr162.9
420–40%Up 0–2%₹1,730 Cr17.5
520–40%Up 0–2%₹580 Cr11.9
6Apollo HospitalsThis stock20–40%Flat₹1.13L Cr53.9

Sign up free to see every company in the sector ranking and track Apollo Hospitals Enterprise Ltd.

Pro shows every company guiding 40%+ revenue growth →Full Healthcare Services ranking

Financials of Apollo Hospitals Enterprise Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Apollo Hospitals Enterprise Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +4,3024,4184,8474,8514,9445,0865,5895,5275,5925,8426,3046,4776,606
Expenses +3,8143,9094,2194,2374,3034,4104,7744,7654,8224,9905,3625,5125,594
Operating Profit4885096286146406758167627708529419651,011
OPM %11%12%13%13%13%13%15%14%14%15%15%15%15%
Other Income +20342629374944697254614854
Interest95106111113119116118110115108110113119
Depreciation159167163167190177184185211215218219224
Profit before tax254270379363368430557536516583675682722
Tax %43%36%34%30%30%27%29%29%20%24%27%24%24%
Net Profit +146173249254258316396379414441494516551
EPS in Rs10.0511.5916.2017.0617.6521.2326.3425.8927.1030.1033.1934.9336.81

Financials of Apollo Hospitals Enterprise Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +5,1296,1507,2568,2439,61711,24710,56014,66316,61219,05921,79425,228
Expenses +4,3925,4656,5227,4428,5489,6569,42012,47414,54816,66518,76121,459
Operating Profit7376847348011,0701,5911,1402,1892,0652,3943,0333,769
OPM %14%11%10%10%11%14%11%15%12%13%14%15%
Other Income +479260242622210336875123222217
Interest118180257295327533449379381449458450
Depreciation212264314359396620573601615687758876
Profit before tax4553322221713736602211,5781,1441,3802,0392,661
Tax %29%29%41%65%47%34%38%30%22%32%26%25%
Net Profit +335235131602004321371,1088449351,5052,003
EPS in Rs24.4316.9915.888.4416.9632.7010.4673.4256.9762.50100.56135.04
Dividend Payout %24%35%38%59%35%18%29%16%26%26%13%15%

Financials of Apollo Hospitals Enterprise Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital707070707070727272727272
Reserves3,1023,2623,2443,1823,2643,2704,5315,5516,1266,8648,1409,408
Borrowings +1,9922,8343,1253,4273,6733,5964,1604,0684,3325,3337,8648,493
Other Liabilities +1,2961,1951,6651,9172,1594,3542,6293,5703,8864,4744,5684,224
Total Liabilities6,4597,3608,1038,5969,16611,28911,39213,26114,41616,74220,64422,197
Fixed Assets +3,2443,9974,5914,7734,9827,4326,7788,2968,5209,66410,98812,312
CWIP53356234771282223623446610873921992
Investments3113524063524624341,3438165749862,4872,179
Other Assets +2,3722,4482,7592,7592,9013,1873,0374,1044,7125,2196,2486,714
Total Assets6,4597,3608,1038,5969,16611,28911,39213,26114,41616,74220,64422,197

Financials of Apollo Hospitals Enterprise Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +4705976235379051,2931,2651,6961,3771,9202,1362,856
Cash from Investing Activity +-759-888-1,152-405-711-289-880-747-857-1,537-3,381-2,148
Cash from Financing Activity +392330477-108-215-910-340-792-633-3111,317-478
Net Cash Flow10339-5224-209444158-1137273230
Free Cash Flow-396-393-46-842337829841,044252785439925
CFO/OP77%108%103%83%103%100%108%87%85%100%86%92%

Financials of Apollo Hospitals Enterprise Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days433638373933464449485150
Inventory Days504947514649162117171615
Days Payable596651555660747982887263
Cash Conversion Cycle341934332922-12-14-16-23-63
Working Capital Days2416278-3-8-45-1-19-6-10
ROCE %12%9%8%7%10%14%8%17%14%15%17%18%

Guidance history

How Apollo Hospitals Enterprise Ltd's guidance has moved, call by call

CallRevenueMarginsCapexFundraisingOrder book
Q1 FY27 call →20–40%FlatPlanned——
Q4 FY26 call →20–40%Up 0–2%Planned——
Q3 FY26 call →20–40%FlatPlanned——
Q2 FY26 call →10–20%FlatPlanned——

What management guided on each call, newest first. Not investment advice, and not a forecast of returns.

66out of 100

Momentum score · price trend

66 out of 100 — Steady

Over the past year its share price has moved roughly in the middle of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months+8.4%68%
Last 6 months+10.6%69%
Last 3 months−5.7%56%
How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Apollo Hospitals Enterprise Ltd: 0.4 × 68 + 0.4 × 69 + 0.2 × 56 = 66.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 30 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Continue your research

What Apollo Hospitals Enterprise Ltd's management said in earlier quarters

Others in Healthcare Services this season

  • Narayana Hrudayalaya Ltd (Q2 FY27)

    Consolidated operating revenue for Q2 FY27: ₹28,440 Mn, up 73.0% YoY (Page 15, 16). Key investor presentation takeaways from Narayana Hrudayalaya Ltd's Q2 FY27

  • Artemis Medicare Services Ltd (Q2 FY27)

    Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY (Page 39, 40, 20). Key investor presentation takeaways from Artemis Medicare Service

  • Max Healthcare Institute Ltd (Q2 FY27)

    Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY (Page 4, 17) . Key investor presentation takeaways from Max Healthcare Institute Ltd's Q2 FY27 investor presentatio

  • Indegene Ltd (Q2 FY27)

    Revenue from operations for Q2 FY27: INR 11,223 million, up 39.5% YoY (Page 23, 15, 4) . Key investor presentation takeaways from Indegene Ltd's Q2 FY27 investo

Compare:vs Manipal Health Enterprises Ltdvs Max Healthcare Institute Ltdvs Aster DM Quality Care Ltd